3hop - Revision history

OCA at 15:51, 1 November 2023

OCA — Wed, 01 Nov 2023 15:51:59 GMT

←Older revision		Revision as of 15:51, 1 November 2023
Line 3:		Line 3:
	<StructureSection load='3hop' size='340' side='right'caption='[[3hop]], [[Resolution\|resolution]] 2.30Å' scene=''>		<StructureSection load='3hop' size='340' side='right'caption='[[3hop]], [[Resolution\|resolution]] 2.30Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[3hop]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3HOP FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[3hop]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3HOP FirstGlance]. <br>
-	</td></tr><tr id='~~ligand~~'><td class="sblockLbl"><b>[[~~Ligand~~\|~~Ligands~~:]]</b></td><td class="sblockDat" id="~~ligandDat~~">~~<scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene>~~</td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.3Å</td></tr>
-	<tr id='~~related~~'><td class="sblockLbl"><b>[[~~Related_structure~~\|~~Related~~:]]</b></td><td class="sblockDat"~~><div style~~=~~'overflow: auto; max-height: 3em;'~~>~~[[3hoc\|3hoc]], [[3hor\|3hor]]~~<~~/div></td></tr>~~	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr>
-	~~<tr id~~='~~gene'><td class~~=~~"sblockLbl"><b>[[Gene\|Gene~~:~~]]</b~~></td>~~<td class="sblockDat">FLNA ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])~~</td></tr>	+
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3hop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hop OCA], [https://pdbe.org/3hop PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3hop RCSB], [https://www.ebi.ac.uk/pdbsum/3hop PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3hop ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3hop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hop OCA], [https://pdbe.org/3hop PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3hop RCSB], [https://www.ebi.ac.uk/pdbsum/3hop PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3hop ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
-	[[https://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Defects in FLNA are the cause of periventricular nodular heterotopia type 1 (PVNH1) [MIM:[https://omim.org/entry/300049 300049]]; also called nodular heterotopia, bilateral periventricular (NHBP or BPNH). PVNH is a developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a failure of neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X-linked dominant form. Heterozygous females have normal intelligence but suffer from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.<ref>PMID:16299064</ref> <ref>PMID:11532987</ref> <ref>PMID:12410386</ref> <ref>PMID:11914408</ref> <ref>PMID:15249610</ref> Defects in FLNA are the cause of periventricular nodular heterotopia type 4 (PVNH4) [MIM:[https://omim.org/entry/300537 300537]]; also known as periventricular heterotopia Ehlers-Danlos variant. PVNH4 is characterized by nodular brain heterotopia, joint hypermobility and development of aortic dilation in early adulthood. Defects in FLNA are the cause of otopalatodigital syndrome type 1 (OPD1) [MIM:[https://omim.org/entry/311300 311300]]. OPD1 is an X-linked dominant multiple congenital anomalies disease mainly characterized by a generalized skeletal dysplasia, mild mental retardation, hearing loss, cleft palate, and typical facial anomalies. OPD1 belongs to a group of X-linked skeletal dysplasias known as oto-palato-digital syndrome spectrum disorders that also include OPD2, Melnick-Needles syndrome (MNS), and frontometaphyseal dysplasia (FMD). Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. FLNA is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers. Males with OPD1 have cleft palate, malformations of the ossicles causing deafness and milder bone and limb defects than those associated with OPD2. Obligate female carriers of mutations causing both OPD1 and OPD2 have variable (often milder) expression of a similar phenotypic spectrum.<ref>PMID:12612583</ref> <ref>PMID:15940695</ref> Defects in FLNA are the cause of otopalatodigital syndrome type 2 (OPD2) [MIM:[https://omim.org/entry/304120 304120]]; also known as cranioorodigital syndrome. OPD2 is a congenital bone disorder that is characterized by abnormally modeled, bowed bones, small or absent first digits and, more variably, cleft palate, posterior fossa brain anomalies, omphalocele and cardiac defects. Defects in FLNA are the cause of frontometaphyseal dysplasia (FMD) [MIM:[https://omim.org/entry/305620 305620]]. FMD is a congenital bone disease characterized by supraorbital hyperostosis, deafness and digital anomalies.<ref>PMID:12612583</ref> <ref>PMID:16596676</ref> Defects in FLNA are the cause of Melnick-Needles syndrome (MNS) [MIM:[https://omim.org/entry/309350 309350]]. MNS is a severe congenital bone disorder characterized by typical facies (exophthalmos, full cheeks, micrognathia and malalignment of teeth), flaring of the metaphyses of long bones, s-like curvature of bones of legs, irregular constrictions in the ribs, and sclerosis of base of skull.<ref>PMID:12612583</ref> Defects in FLNA are the cause of X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX) [MIM:[https://omim.org/entry/300048 300048]]. CIIPX is characterized by a severe abnormality of gastrointestinal motility due to primary qualitative defects of enteric ganglia and nerve fibers. Affected individuals manifest recurrent signs of intestinal obstruction in the absence of any mechanical lesion.<ref>PMID:17357080</ref> Defects in FLNA are the cause of FG syndrome type 2 (FGS2) [MIM:[https://omim.org/entry/300321 300321]]. FG syndrome (FGS) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation.<ref>PMID:17632775</ref> Defects in FLNA are the cause of terminal osseous dysplasia (TOD) [MIM:[https://omim.org/entry/300244 300244]]. A rare X-linked dominant male-lethal disease characterized by skeletal dysplasia of the limbs, pigmentary defects of the skin and recurrent digital fibroma during infancy. A significant phenotypic variability is observed in affected females.<ref>PMID:20598277</ref> Defects in FLNA are the cause of cardiac valvular dysplasia X-linked (CVDX) [MIM:[https://omim.org/entry/314400 314400]]. A rare X-linked heart disease characterized by mitral and/or aortic valve regurgitation. The histologic features include fragmentation of collagenous bundles within the valve fibrosa and accumulation of proteoglycans, which produces excessive valve tissue leading to billowing of the valve leaflets.<ref>PMID:17190868</ref> Note=Defects in FLNA may be a cause of macrothrombocytopenia, a disorder characterized by subnormal levels of blood platelets. Blood platelets are abonormally enlarged.	+	[https://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN] Defects in FLNA are the cause of periventricular nodular heterotopia type 1 (PVNH1) [MIM:[https://omim.org/entry/300049 300049]; also called nodular heterotopia, bilateral periventricular (NHBP or BPNH). PVNH is a developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a failure of neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X-linked dominant form. Heterozygous females have normal intelligence but suffer from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.<ref>PMID:16299064</ref> <ref>PMID:11532987</ref> <ref>PMID:12410386</ref> <ref>PMID:11914408</ref> <ref>PMID:15249610</ref> Defects in FLNA are the cause of periventricular nodular heterotopia type 4 (PVNH4) [MIM:[https://omim.org/entry/300537 300537]; also known as periventricular heterotopia Ehlers-Danlos variant. PVNH4 is characterized by nodular brain heterotopia, joint hypermobility and development of aortic dilation in early adulthood. Defects in FLNA are the cause of otopalatodigital syndrome type 1 (OPD1) [MIM:[https://omim.org/entry/311300 311300]. OPD1 is an X-linked dominant multiple congenital anomalies disease mainly characterized by a generalized skeletal dysplasia, mild mental retardation, hearing loss, cleft palate, and typical facial anomalies. OPD1 belongs to a group of X-linked skeletal dysplasias known as oto-palato-digital syndrome spectrum disorders that also include OPD2, Melnick-Needles syndrome (MNS), and frontometaphyseal dysplasia (FMD). Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. FLNA is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers. Males with OPD1 have cleft palate, malformations of the ossicles causing deafness and milder bone and limb defects than those associated with OPD2. Obligate female carriers of mutations causing both OPD1 and OPD2 have variable (often milder) expression of a similar phenotypic spectrum.<ref>PMID:12612583</ref> <ref>PMID:15940695</ref> Defects in FLNA are the cause of otopalatodigital syndrome type 2 (OPD2) [MIM:[https://omim.org/entry/304120 304120]; also known as cranioorodigital syndrome. OPD2 is a congenital bone disorder that is characterized by abnormally modeled, bowed bones, small or absent first digits and, more variably, cleft palate, posterior fossa brain anomalies, omphalocele and cardiac defects. Defects in FLNA are the cause of frontometaphyseal dysplasia (FMD) [MIM:[https://omim.org/entry/305620 305620]. FMD is a congenital bone disease characterized by supraorbital hyperostosis, deafness and digital anomalies.<ref>PMID:12612583</ref> <ref>PMID:16596676</ref> Defects in FLNA are the cause of Melnick-Needles syndrome (MNS) [MIM:[https://omim.org/entry/309350 309350]. MNS is a severe congenital bone disorder characterized by typical facies (exophthalmos, full cheeks, micrognathia and malalignment of teeth), flaring of the metaphyses of long bones, s-like curvature of bones of legs, irregular constrictions in the ribs, and sclerosis of base of skull.<ref>PMID:12612583</ref> Defects in FLNA are the cause of X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX) [MIM:[https://omim.org/entry/300048 300048]. CIIPX is characterized by a severe abnormality of gastrointestinal motility due to primary qualitative defects of enteric ganglia and nerve fibers. Affected individuals manifest recurrent signs of intestinal obstruction in the absence of any mechanical lesion.<ref>PMID:17357080</ref> Defects in FLNA are the cause of FG syndrome type 2 (FGS2) [MIM:[https://omim.org/entry/300321 300321]. FG syndrome (FGS) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation.<ref>PMID:17632775</ref> Defects in FLNA are the cause of terminal osseous dysplasia (TOD) [MIM:[https://omim.org/entry/300244 300244]. A rare X-linked dominant male-lethal disease characterized by skeletal dysplasia of the limbs, pigmentary defects of the skin and recurrent digital fibroma during infancy. A significant phenotypic variability is observed in affected females.<ref>PMID:20598277</ref> Defects in FLNA are the cause of cardiac valvular dysplasia X-linked (CVDX) [MIM:[https://omim.org/entry/314400 314400]. A rare X-linked heart disease characterized by mitral and/or aortic valve regurgitation. The histologic features include fragmentation of collagenous bundles within the valve fibrosa and accumulation of proteoglycans, which produces excessive valve tissue leading to billowing of the valve leaflets.<ref>PMID:17190868</ref> Note=Defects in FLNA may be a cause of macrothrombocytopenia, a disorder characterized by subnormal levels of blood platelets. Blood platelets are abonormally enlarged.
	== Function ==		== Function ==
-	[[https://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis.<ref>PMID:22121117</ref>	+	[https://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN] Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis.<ref>PMID:22121117</ref>
	== Evolutionary Conservation ==		== Evolutionary Conservation ==
	[[Image:Consurf_key_small.gif\|200px\|right]]		[[Image:Consurf_key_small.gif\|200px\|right]]
Line 40:		Line 39:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Clark~~, A R~~]]	+	[[Category: Clark AR]]
-	[[Category: Robertson~~, S P~~]]	+	[[Category: Robertson SP]]
-	[[Category: Sawyer~~, G M~~]]	+	[[Category: Sawyer GM]]
-	[[Category: Sutherland-Smith~~, A J]]~~	+	[[Category: Sutherland-Smith AJ]]
-	~~[[Category: Acetylation]]~~	+
-	~~[[Category: Actin binding domain]]~~	+
-	~~[[Category: Actin-binding]]~~	+
-	~~[[Category: Alternative splicing]]~~	+
-	~~[[Category: Calponin homology domain]]~~	+
-	~~[[Category: Cytoplasm]]~~	+
-	~~[[Category: Cytoskeleton]]~~	+
-	~~[[Category: Disease mutation]]~~	+
-	~~[[Category: Phosphoprotein]]~~	+
-	~~[[Category: Polymorphism]]~~	+
-	~~[[Category: Structural protein~~]]	+

OCA at 12:54, 23 March 2022

OCA — Wed, 23 Mar 2022 12:54:48 GMT

←Older revision		Revision as of 12:54, 23 March 2022
Line 1:		Line 1:

	==Structure of the actin-binding domain of human filamin A==		==Structure of the actin-binding domain of human filamin A==
-	<StructureSection load='3hop' size='340' side='right' caption='[[3hop]], [[Resolution\|resolution]] 2.30Å' scene=''>	+	<StructureSection load='3hop' size='340' side='right'caption='[[3hop]], [[Resolution\|resolution]] 2.30Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[3hop]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=3HOP FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[3hop]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3HOP FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr>
-	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3hoc\|3hoc]], [[3hor\|3hor]]</td></tr>	+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[3hoc\|3hoc]], [[3hor\|3hor]]</div></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">FLNA ([~~http~~://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">FLNA ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=3hop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hop OCA], [~~http~~://pdbe.org/3hop PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=3hop RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/3hop PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=3hop ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3hop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hop OCA], [https://pdbe.org/3hop PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3hop RCSB], [https://www.ebi.ac.uk/pdbsum/3hop PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3hop ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
-	[[~~http~~://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Defects in FLNA are the cause of periventricular nodular heterotopia type 1 (PVNH1) [MIM:[~~http~~://omim.org/entry/300049 300049]]; also called nodular heterotopia, bilateral periventricular (NHBP or BPNH). PVNH is a developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a failure of neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X-linked dominant form. Heterozygous females have normal intelligence but suffer from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.<ref>PMID:16299064</ref> <ref>PMID:11532987</ref> <ref>PMID:12410386</ref> <ref>PMID:11914408</ref> <ref>PMID:15249610</ref> Defects in FLNA are the cause of periventricular nodular heterotopia type 4 (PVNH4) [MIM:[~~http~~://omim.org/entry/300537 300537]]; also known as periventricular heterotopia Ehlers-Danlos variant. PVNH4 is characterized by nodular brain heterotopia, joint hypermobility and development of aortic dilation in early adulthood. Defects in FLNA are the cause of otopalatodigital syndrome type 1 (OPD1) [MIM:[~~http~~://omim.org/entry/311300 311300]]. OPD1 is an X-linked dominant multiple congenital anomalies disease mainly characterized by a generalized skeletal dysplasia, mild mental retardation, hearing loss, cleft palate, and typical facial anomalies. OPD1 belongs to a group of X-linked skeletal dysplasias known as oto-palato-digital syndrome spectrum disorders that also include OPD2, Melnick-Needles syndrome (MNS), and frontometaphyseal dysplasia (FMD). Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. FLNA is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers. Males with OPD1 have cleft palate, malformations of the ossicles causing deafness and milder bone and limb defects than those associated with OPD2. Obligate female carriers of mutations causing both OPD1 and OPD2 have variable (often milder) expression of a similar phenotypic spectrum.<ref>PMID:12612583</ref> <ref>PMID:15940695</ref> Defects in FLNA are the cause of otopalatodigital syndrome type 2 (OPD2) [MIM:[~~http~~://omim.org/entry/304120 304120]]; also known as cranioorodigital syndrome. OPD2 is a congenital bone disorder that is characterized by abnormally modeled, bowed bones, small or absent first digits and, more variably, cleft palate, posterior fossa brain anomalies, omphalocele and cardiac defects. Defects in FLNA are the cause of frontometaphyseal dysplasia (FMD) [MIM:[~~http~~://omim.org/entry/305620 305620]]. FMD is a congenital bone disease characterized by supraorbital hyperostosis, deafness and digital anomalies.<ref>PMID:12612583</ref> <ref>PMID:16596676</ref> Defects in FLNA are the cause of Melnick-Needles syndrome (MNS) [MIM:[~~http~~://omim.org/entry/309350 309350]]. MNS is a severe congenital bone disorder characterized by typical facies (exophthalmos, full cheeks, micrognathia and malalignment of teeth), flaring of the metaphyses of long bones, s-like curvature of bones of legs, irregular constrictions in the ribs, and sclerosis of base of skull.<ref>PMID:12612583</ref> Defects in FLNA are the cause of X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX) [MIM:[~~http~~://omim.org/entry/300048 300048]]. CIIPX is characterized by a severe abnormality of gastrointestinal motility due to primary qualitative defects of enteric ganglia and nerve fibers. Affected individuals manifest recurrent signs of intestinal obstruction in the absence of any mechanical lesion.<ref>PMID:17357080</ref> Defects in FLNA are the cause of FG syndrome type 2 (FGS2) [MIM:[~~http~~://omim.org/entry/300321 300321]]. FG syndrome (FGS) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation.<ref>PMID:17632775</ref> Defects in FLNA are the cause of terminal osseous dysplasia (TOD) [MIM:[~~http~~://omim.org/entry/300244 300244]]. A rare X-linked dominant male-lethal disease characterized by skeletal dysplasia of the limbs, pigmentary defects of the skin and recurrent digital fibroma during infancy. A significant phenotypic variability is observed in affected females.<ref>PMID:20598277</ref> Defects in FLNA are the cause of cardiac valvular dysplasia X-linked (CVDX) [MIM:[~~http~~://omim.org/entry/314400 314400]]. A rare X-linked heart disease characterized by mitral and/or aortic valve regurgitation. The histologic features include fragmentation of collagenous bundles within the valve fibrosa and accumulation of proteoglycans, which produces excessive valve tissue leading to billowing of the valve leaflets.<ref>PMID:17190868</ref> Note=Defects in FLNA may be a cause of macrothrombocytopenia, a disorder characterized by subnormal levels of blood platelets. Blood platelets are abonormally enlarged.	+	[[https://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Defects in FLNA are the cause of periventricular nodular heterotopia type 1 (PVNH1) [MIM:[https://omim.org/entry/300049 300049]]; also called nodular heterotopia, bilateral periventricular (NHBP or BPNH). PVNH is a developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a failure of neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X-linked dominant form. Heterozygous females have normal intelligence but suffer from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.<ref>PMID:16299064</ref> <ref>PMID:11532987</ref> <ref>PMID:12410386</ref> <ref>PMID:11914408</ref> <ref>PMID:15249610</ref> Defects in FLNA are the cause of periventricular nodular heterotopia type 4 (PVNH4) [MIM:[https://omim.org/entry/300537 300537]]; also known as periventricular heterotopia Ehlers-Danlos variant. PVNH4 is characterized by nodular brain heterotopia, joint hypermobility and development of aortic dilation in early adulthood. Defects in FLNA are the cause of otopalatodigital syndrome type 1 (OPD1) [MIM:[https://omim.org/entry/311300 311300]]. OPD1 is an X-linked dominant multiple congenital anomalies disease mainly characterized by a generalized skeletal dysplasia, mild mental retardation, hearing loss, cleft palate, and typical facial anomalies. OPD1 belongs to a group of X-linked skeletal dysplasias known as oto-palato-digital syndrome spectrum disorders that also include OPD2, Melnick-Needles syndrome (MNS), and frontometaphyseal dysplasia (FMD). Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. FLNA is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers. Males with OPD1 have cleft palate, malformations of the ossicles causing deafness and milder bone and limb defects than those associated with OPD2. Obligate female carriers of mutations causing both OPD1 and OPD2 have variable (often milder) expression of a similar phenotypic spectrum.<ref>PMID:12612583</ref> <ref>PMID:15940695</ref> Defects in FLNA are the cause of otopalatodigital syndrome type 2 (OPD2) [MIM:[https://omim.org/entry/304120 304120]]; also known as cranioorodigital syndrome. OPD2 is a congenital bone disorder that is characterized by abnormally modeled, bowed bones, small or absent first digits and, more variably, cleft palate, posterior fossa brain anomalies, omphalocele and cardiac defects. Defects in FLNA are the cause of frontometaphyseal dysplasia (FMD) [MIM:[https://omim.org/entry/305620 305620]]. FMD is a congenital bone disease characterized by supraorbital hyperostosis, deafness and digital anomalies.<ref>PMID:12612583</ref> <ref>PMID:16596676</ref> Defects in FLNA are the cause of Melnick-Needles syndrome (MNS) [MIM:[https://omim.org/entry/309350 309350]]. MNS is a severe congenital bone disorder characterized by typical facies (exophthalmos, full cheeks, micrognathia and malalignment of teeth), flaring of the metaphyses of long bones, s-like curvature of bones of legs, irregular constrictions in the ribs, and sclerosis of base of skull.<ref>PMID:12612583</ref> Defects in FLNA are the cause of X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX) [MIM:[https://omim.org/entry/300048 300048]]. CIIPX is characterized by a severe abnormality of gastrointestinal motility due to primary qualitative defects of enteric ganglia and nerve fibers. Affected individuals manifest recurrent signs of intestinal obstruction in the absence of any mechanical lesion.<ref>PMID:17357080</ref> Defects in FLNA are the cause of FG syndrome type 2 (FGS2) [MIM:[https://omim.org/entry/300321 300321]]. FG syndrome (FGS) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation.<ref>PMID:17632775</ref> Defects in FLNA are the cause of terminal osseous dysplasia (TOD) [MIM:[https://omim.org/entry/300244 300244]]. A rare X-linked dominant male-lethal disease characterized by skeletal dysplasia of the limbs, pigmentary defects of the skin and recurrent digital fibroma during infancy. A significant phenotypic variability is observed in affected females.<ref>PMID:20598277</ref> Defects in FLNA are the cause of cardiac valvular dysplasia X-linked (CVDX) [MIM:[https://omim.org/entry/314400 314400]]. A rare X-linked heart disease characterized by mitral and/or aortic valve regurgitation. The histologic features include fragmentation of collagenous bundles within the valve fibrosa and accumulation of proteoglycans, which produces excessive valve tissue leading to billowing of the valve leaflets.<ref>PMID:17190868</ref> Note=Defects in FLNA may be a cause of macrothrombocytopenia, a disorder characterized by subnormal levels of blood platelets. Blood platelets are abonormally enlarged.
	== Function ==		== Function ==
-	[[~~http~~://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis.<ref>PMID:22121117</ref>	+	[[https://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis.<ref>PMID:22121117</ref>
	== Evolutionary Conservation ==		== Evolutionary Conservation ==
	[[Image:Consurf_key_small.gif\|200px\|right]]		[[Image:Consurf_key_small.gif\|200px\|right]]
	Check<jmol>		Check<jmol>
	<jmolCheckbox>		<jmolCheckbox>
-	<scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/ho/3hop_consurf.spt"</scriptWhenChecked>	+	<scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/ho/3hop_consurf.spt"</scriptWhenChecked>
	<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>		<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
	<text>to colour the structure by Evolutionary Conservation</text>		<text>to colour the structure by Evolutionary Conservation</text>
Line 32:		Line 32:
	</div>		</div>
	<div class="pdbe-citations 3hop" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 3hop" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Filamin 3D structures\|Filamin 3D structures]]
		+	*[[User:Georg Mlynek/workbench\|User:Georg Mlynek/workbench]]
	== References ==		== References ==
	<references/>		<references/>
Line 37:		Line 41:
	</StructureSection>		</StructureSection>
	[[Category: Human]]		[[Category: Human]]
		+	[[Category: Large Structures]]
	[[Category: Clark, A R]]		[[Category: Clark, A R]]
	[[Category: Robertson, S P]]		[[Category: Robertson, S P]]

OCA at 07:43, 1 November 2017

OCA — Wed, 01 Nov 2017 07:43:11 GMT

←Older revision		Revision as of 07:43, 1 November 2017
Line 1:		Line 1:
		+
	==Structure of the actin-binding domain of human filamin A==		==Structure of the actin-binding domain of human filamin A==
	<StructureSection load='3hop' size='340' side='right' caption='[[3hop]], [[Resolution\|resolution]] 2.30Å' scene=''>		<StructureSection load='3hop' size='340' side='right' caption='[[3hop]], [[Resolution\|resolution]] 2.30Å' scene=''>
Line 6:		Line 7:
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3hoc\|3hoc]], [[3hor\|3hor]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3hoc\|3hoc]], [[3hor\|3hor]]</td></tr>
	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">FLNA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>		<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">FLNA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3hop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hop OCA], [http://pdbe.org/3hop PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3hop RCSB], [http://www.ebi.ac.uk/pdbsum/3hop PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3hop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hop OCA], [http://pdbe.org/3hop PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3hop RCSB], [http://www.ebi.ac.uk/pdbsum/3hop PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=3hop ProSAT]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 31:		Line 32:
	</div>		</div>
	<div class="pdbe-citations 3hop" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 3hop" style="background-color:#fffaf0;"></div>
-
-	==See Also==
-	*[[Filamin\|Filamin]]
-	*[[User:Georg Mlynek/workbench\|User:Georg Mlynek/workbench]]
	== References ==		== References ==
	<references/>		<references/>
Line 44:		Line 41:
	[[Category: Sawyer, G M]]		[[Category: Sawyer, G M]]
	[[Category: Sutherland-Smith, A J]]		[[Category: Sutherland-Smith, A J]]
		+	[[Category: Acetylation]]
	[[Category: Actin binding domain]]		[[Category: Actin binding domain]]
	[[Category: Actin-binding]]		[[Category: Actin-binding]]
		+	[[Category: Alternative splicing]]
	[[Category: Calponin homology domain]]		[[Category: Calponin homology domain]]
		+	[[Category: Cytoplasm]]
	[[Category: Cytoskeleton]]		[[Category: Cytoskeleton]]
	[[Category: Disease mutation]]		[[Category: Disease mutation]]
	[[Category: Phosphoprotein]]		[[Category: Phosphoprotein]]
		+	[[Category: Polymorphism]]
	[[Category: Structural protein]]		[[Category: Structural protein]]

OCA at 21:46, 7 February 2016

OCA — Sun, 07 Feb 2016 21:46:29 GMT

←Older revision		Revision as of 21:46, 7 February 2016
Line 2:		Line 2:
	<StructureSection load='3hop' size='340' side='right' caption='[[3hop]], [[Resolution\|resolution]] 2.30Å' scene=''>		<StructureSection load='3hop' size='340' side='right' caption='[[3hop]], [[Resolution\|resolution]] 2.30Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[3hop]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/~~Homo_sapiens Homo sapiens~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3HOP FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[3hop]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3HOP FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3hoc\|3hoc]], [[3hor\|3hor]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3hoc\|3hoc]], [[3hor\|3hor]]</td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">FLNA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 ~~Homo sapiens~~])</td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">FLNA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3hop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hop OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3hop RCSB], [http://www.ebi.ac.uk/pdbsum/3hop PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3hop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hop OCA], [http://pdbe.org/3hop PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=3hop RCSB], [http://www.ebi.ac.uk/pdbsum/3hop PDBsum]</span></td></tr>
	</table>		</table>
	== Disease ==		== Disease ==
Line 20:		Line 20:
	<text>to colour the structure by Evolutionary Conservation</text>		<text>to colour the structure by Evolutionary Conservation</text>
	</jmolCheckbox>		</jmolCheckbox>
-	</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary\|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/~~chain_selection~~.php?pdb_ID=~~2ata~~ ConSurf].	+	</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary\|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=3hop ConSurf].
	<div style="clear:both"></div>		<div style="clear:both"></div>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 30:		Line 30:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 3hop" style="background-color:#fffaf0;"></div>

	==See Also==		==See Also==
Line 38:		Line 39:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Homo sapiens~~]]	+	[[Category: Human]]
	[[Category: Clark, A R]]		[[Category: Clark, A R]]
	[[Category: Robertson, S P]]		[[Category: Robertson, S P]]

OCA at 16:29, 18 December 2014

OCA — Thu, 18 Dec 2014 16:29:18 GMT

←Older revision		Revision as of 16:29, 18 December 2014
Line 1:		Line 1:
-	~~{{STRUCTURE_3hop~~\| ~~PDB~~=3hop \| ~~SCENE~~= }}	+	==Structure of the actin-binding domain of human filamin A==
-	===~~Structure~~ of the actin-~~binding domain~~ of ~~human filamin~~ A===	+	<StructureSection load='3hop' size='340' side='right' caption='[[3hop]], [[Resolution\|resolution]] 2.30Å' scene=''>
-	~~{{ABSTRACT_PUBMED_19773341}}~~	+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[3hop]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3HOP FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr>
		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[3hoc\|3hoc]], [[3hor\|3hor]]</td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">FLNA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=3hop FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3hop OCA], [http://www.rcsb.org/pdb/explore.do?structureId=3hop RCSB], [http://www.ebi.ac.uk/pdbsum/3hop PDBsum]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[[http://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Defects in FLNA are the cause of periventricular nodular heterotopia type 1 (PVNH1) [MIM:[http://omim.org/entry/300049 300049]]; also called nodular heterotopia, bilateral periventricular (NHBP or BPNH). PVNH is a developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a failure of neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X-linked dominant form. Heterozygous females have normal intelligence but suffer from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.<ref>PMID:16299064</ref> <ref>PMID:11532987</ref> <ref>PMID:12410386</ref> <ref>PMID:11914408</ref> <ref>PMID:15249610</ref> Defects in FLNA are the cause of periventricular nodular heterotopia type 4 (PVNH4) [MIM:[http://omim.org/entry/300537 300537]]; also known as periventricular heterotopia Ehlers-Danlos variant. PVNH4 is characterized by nodular brain heterotopia, joint hypermobility and development of aortic dilation in early adulthood. Defects in FLNA are the cause of otopalatodigital syndrome type 1 (OPD1) [MIM:[http://omim.org/entry/311300 311300]]. OPD1 is an X-linked dominant multiple congenital anomalies disease mainly characterized by a generalized skeletal dysplasia, mild mental retardation, hearing loss, cleft palate, and typical facial anomalies. OPD1 belongs to a group of X-linked skeletal dysplasias known as oto-palato-digital syndrome spectrum disorders that also include OPD2, Melnick-Needles syndrome (MNS), and frontometaphyseal dysplasia (FMD). Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. FLNA is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers. Males with OPD1 have cleft palate, malformations of the ossicles causing deafness and milder bone and limb defects than those associated with OPD2. Obligate female carriers of mutations causing both OPD1 and OPD2 have variable (often milder) expression of a similar phenotypic spectrum.<ref>PMID:12612583</ref> <ref>PMID:15940695</ref> Defects in FLNA are the cause of otopalatodigital syndrome type 2 (OPD2) [MIM:[http://omim.org/entry/304120 304120]]; also known as cranioorodigital syndrome. OPD2 is a congenital bone disorder that is characterized by abnormally modeled, bowed bones, small or absent first digits and, more variably, cleft palate, posterior fossa brain anomalies, omphalocele and cardiac defects. Defects in FLNA are the cause of frontometaphyseal dysplasia (FMD) [MIM:[http://omim.org/entry/305620 305620]]. FMD is a congenital bone disease characterized by supraorbital hyperostosis, deafness and digital anomalies.<ref>PMID:12612583</ref> <ref>PMID:16596676</ref> Defects in FLNA are the cause of Melnick-Needles syndrome (MNS) [MIM:[http://omim.org/entry/309350 309350]]. MNS is a severe congenital bone disorder characterized by typical facies (exophthalmos, full cheeks, micrognathia and malalignment of teeth), flaring of the metaphyses of long bones, s-like curvature of bones of legs, irregular constrictions in the ribs, and sclerosis of base of skull.<ref>PMID:12612583</ref> Defects in FLNA are the cause of X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX) [MIM:[http://omim.org/entry/300048 300048]]. CIIPX is characterized by a severe abnormality of gastrointestinal motility due to primary qualitative defects of enteric ganglia and nerve fibers. Affected individuals manifest recurrent signs of intestinal obstruction in the absence of any mechanical lesion.<ref>PMID:17357080</ref> Defects in FLNA are the cause of FG syndrome type 2 (FGS2) [MIM:[http://omim.org/entry/300321 300321]]. FG syndrome (FGS) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation.<ref>PMID:17632775</ref> Defects in FLNA are the cause of terminal osseous dysplasia (TOD) [MIM:[http://omim.org/entry/300244 300244]]. A rare X-linked dominant male-lethal disease characterized by skeletal dysplasia of the limbs, pigmentary defects of the skin and recurrent digital fibroma during infancy. A significant phenotypic variability is observed in affected females.<ref>PMID:20598277</ref> Defects in FLNA are the cause of cardiac valvular dysplasia X-linked (CVDX) [MIM:[http://omim.org/entry/314400 314400]]. A rare X-linked heart disease characterized by mitral and/or aortic valve regurgitation. The histologic features include fragmentation of collagenous bundles within the valve fibrosa and accumulation of proteoglycans, which produces excessive valve tissue leading to billowing of the valve leaflets.<ref>PMID:17190868</ref> Note=Defects in FLNA may be a cause of macrothrombocytopenia, a disorder characterized by subnormal levels of blood platelets. Blood platelets are abonormally enlarged.
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis.<ref>PMID:22121117</ref>
		+	== Evolutionary Conservation ==
		+	[[Image:Consurf_key_small.gif\|200px\|right]]
		+	Check<jmol>
		+	<jmolCheckbox>
		+	<scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/ho/3hop_consurf.spt"</scriptWhenChecked>
		+	<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
		+	<text>to colour the structure by Evolutionary Conservation</text>
		+	</jmolCheckbox>
		+	</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary\|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/chain_selection.php?pdb_ID=2ata ConSurf].
		+	<div style="clear:both"></div>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Filamin A (FLNA) crosslinks F-actin and binds proteins consistent with roles integrating cell signalling and the cytoskeleton. FLNA missense mutations are associated with the otopalatodigital syndrome (OPD) spectrum of skeletal disorders, clustering in discrete domains. One cluster is found in the second calponin homology domain of the FLNA actin-binding domain (ABD), implicating this region as essential for mediating correct function. Here we show that OPD (FLNA E254K) fibroblast lysates have equivalent concentrations of FLNA compared with controls and that recombinant FLNA E254K ABD has increased in vitro F-actin binding (K(d) 13 microm) compared with wild type (WT; K(d) 48 microm). These observations are consistent with a gain-of-function mechanism for OPD. We have determined the crystal structures of the WT and E254K FLNA ABDs at 2.3 A resolution, revealing that they adopt similar closed conformations. The E254K mutation removes a conserved salt bridge but does not disrupt the ABD structure. The solution structures are also equivalent as determined by circular dichroism spectroscopy, but differential scanning fluorimetry denaturation showed reduced stability (decreased T(m) of 5.6 degrees C) for E254K relative to WT. Ex vivo characterization of E254K OPD patient fibroblasts revealed they have similar motility and adhesion as control cells, implying that many core functions mediated by FLNA are unaffected, consistent with OPD only affecting specific tissues despite FLNA being widely expressed. These data provide the first biochemical evidence for a gain-of-function mechanism for the OPD disorders, and mechanistically distinguishes them from the loss-of-function phenotypes that manifest as disorders of neuronal migration.

-	~~==Disease==~~	+	Skeletal dysplasias due to filamin A mutations result from a gain-of-function mechanism distinct from allelic neurological disorders.,Clark AR, Sawyer GM, Robertson SP, Sutherland-Smith AJ Hum Mol Genet. 2009 Dec 15;18(24):4791-800. Epub 2009 Sep 22. PMID:19773341<ref>PMID:19773341</ref>
-	[[http://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Defects in FLNA are the cause of periventricular nodular heterotopia type 1 (PVNH1) [MIM:[http://omim.org/entry/300049 300049]]; also called nodular heterotopia, bilateral periventricular (NHBP or BPNH). PVNH is a developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a ~~failure~~ of ~~neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X~~-~~linked dominant form. Heterozygous females have normal intelligence but suffer~~ from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.<ref>PMID:16299064</ref><ref>PMID:11532987</ref><ref>PMID:12410386</ref><ref>PMID:11914408</ref><ref>PMID:15249610</ref> Defects in FLNA are the cause of periventricular nodular heterotopia type 4 (PVNH4) [MIM:[http://omim.org/entry/300537 300537]]; also known as periventricular heterotopia Ehlers-Danlos variant. ~~PVNH4 is characterized by nodular brain heterotopia~~, joint hypermobility and development of aortic dilation in early adulthood. Defects in FLNA are the cause of otopalatodigital syndrome type 1 (OPD1) [MIM:[http://omim.org/entry/311300 311300]]. OPD1 is an X-linked dominant multiple congenital anomalies disease mainly characterized by a generalized skeletal dysplasia, ~~mild mental retardation~~, ~~hearing loss~~, ~~cleft palate, and typical facial anomalies. OPD1 belongs to a group of X~~-~~linked skeletal dysplasias known as oto-palato-digital syndrome spectrum disorders that also include OPD2, Melnick-Needles syndrome (MNS), and frontometaphyseal dysplasia (FMD)~~. Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. FLNA is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers. Males with OPD1 have cleft palate, malformations of the ossicles causing deafness and milder bone and limb defects than those associated with OPD2. Obligate female carriers of mutations causing both OPD1 and OPD2 have variable (often milder) expression of a similar phenotypic spectrum.<ref>PMID:12612583</ref><ref>PMID:15940695</ref> Defects in FLNA are the cause of otopalatodigital syndrome type 2 (OPD2) [MIM:[http://omim.org/entry/304120 304120]]; also known as cranioorodigital syndrome. OPD2 is a congenital bone disorder that is characterized by abnormally modeled, bowed bones, small or absent first digits and, more variably, cleft palate, posterior fossa brain anomalies, omphalocele and cardiac defects. Defects in FLNA are the cause of frontometaphyseal dysplasia (~~FMD~~) ~~[MIM~~:[http://omim.org/entry/305620 305620]]. FMD is a congenital bone disease characterized by supraorbital hyperostosis, deafness and digital anomalies.<ref>PMID:12612583</ref><ref>PMID:16596676</ref> Defects in FLNA are the cause of Melnick-~~Needles syndrome (MNS) [MIM:[http://omim~~.~~org/entry/309350 309350]]~~. MNS is a severe congenital bone disorder characterized by typical facies (exophthalmos, full cheeks, micrognathia and malalignment of teeth), flaring of the metaphyses of long bones, s-like curvature of bones of legs, irregular constrictions in the ribs, and sclerosis of base of skull.<ref>PMID:12612583</ref> Defects in FLNA are the cause of X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX) [MIM:[http://omim.org/entry/300048 300048]]. CIIPX is characterized by a severe abnormality of gastrointestinal motility due to primary qualitative defects of enteric ganglia and nerve fibers. Affected individuals manifest recurrent signs of intestinal obstruction in the absence of any mechanical lesion.<ref>PMID:~~17357080~~</ref> Defects in FLNA are the cause of FG syndrome type 2 (FGS2) [MIM:[http://omim.org/entry/300321 300321]]. FG syndrome (FGS) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation.<ref>PMID:17632775</ref> Defects in FLNA are the cause of terminal osseous dysplasia (TOD) [MIM:[http://omim.org/entry/300244 300244]]. A rare X-linked dominant male-lethal disease characterized by skeletal dysplasia of the limbs, pigmentary defects of the skin and recurrent digital fibroma during infancy. A significant phenotypic variability is observed in affected females.<ref>PMID:20598277</ref> Defects in FLNA are the cause of cardiac valvular dysplasia X-linked (CVDX) [MIM:[http://omim.org/entry/314400 314400]]. A rare X-linked heart disease characterized by mitral and/or aortic valve regurgitation. The histologic features include fragmentation of collagenous bundles within the valve fibrosa and accumulation of proteoglycans, which produces excessive valve tissue leading to billowing of the valve leaflets.<ref>PMID:17190868</ref> Note=Defects in FLNA may be a cause of macrothrombocytopenia, a disorder characterized by subnormal levels of blood platelets. Blood platelets are abonormally enlarged.	+

-	~~==Function==~~	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	~~[[http:~~//www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a ~~wide range~~ of ~~cytoplasmic signaling proteins. Interaction with FLNA may allow neuroblast migration from the ventricular zone into~~ the ~~cortical plate~~. ~~Tethers cell surface-localized furin, modulates its rate~~ of ~~internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis~~.<~~ref~~>~~PMID:22121117~~</~~ref~~>	+	</div>
-		+
-	~~==About this Structure==~~	+
-	[[3hop]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA].	+

	==See Also==		==See Also==
	*[[Filamin\|Filamin]]		*[[Filamin\|Filamin]]
-		+	*[[User:Georg Mlynek/workbench\|User:Georg Mlynek/workbench]]
-	==~~Reference~~==	+	== References ==
-	~~<ref group="xtra">PMID:019773341</ref>~~<references ~~group="xtra"~~/><~~references~~/>	+	<references/>
		+	__TOC__
		+	</StructureSection>
	[[Category: Homo sapiens]]		[[Category: Homo sapiens]]
-	[[Category: Clark, A R.]]	+	[[Category: Clark, A R]]
-	[[Category: Robertson, S P.]]	+	[[Category: Robertson, S P]]
-	[[Category: Sawyer, G M.]]	+	[[Category: Sawyer, G M]]
-	[[Category: Sutherland-Smith, A J.]]	+	[[Category: Sutherland-Smith, A J]]
	[[Category: Actin binding domain]]		[[Category: Actin binding domain]]
	[[Category: Actin-binding]]		[[Category: Actin-binding]]

OCA at 00:50, 25 March 2013

OCA — Mon, 25 Mar 2013 00:50:05 GMT

←Older revision		Revision as of 00:50, 25 March 2013
Line 1:		Line 1:
-	[[Image:3hop.png\|left\|200px]]
-
	{{STRUCTURE_3hop\| PDB=3hop \| SCENE= }}		{{STRUCTURE_3hop\| PDB=3hop \| SCENE= }}
-
	===Structure of the actin-binding domain of human filamin A===		===Structure of the actin-binding domain of human filamin A===
		+	{{ABSTRACT_PUBMED_19773341}}

-	~~{{ABSTRACT_PUBMED_19773341}}~~	+	==Disease==
		+	[[http://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Defects in FLNA are the cause of periventricular nodular heterotopia type 1 (PVNH1) [MIM:[http://omim.org/entry/300049 300049]]; also called nodular heterotopia, bilateral periventricular (NHBP or BPNH). PVNH is a developmental disorder characterized by the presence of periventricular nodules of cerebral gray matter, resulting from a failure of neurons to migrate normally from the lateral ventricular proliferative zone, where they are formed, to the cerebral cortex. PVNH1 is an X-linked dominant form. Heterozygous females have normal intelligence but suffer from seizures and various manifestations outside the central nervous system, especially related to the vascular system. Hemizygous affected males die in the prenatal or perinatal period.<ref>PMID:16299064</ref><ref>PMID:11532987</ref><ref>PMID:12410386</ref><ref>PMID:11914408</ref><ref>PMID:15249610</ref> Defects in FLNA are the cause of periventricular nodular heterotopia type 4 (PVNH4) [MIM:[http://omim.org/entry/300537 300537]]; also known as periventricular heterotopia Ehlers-Danlos variant. PVNH4 is characterized by nodular brain heterotopia, joint hypermobility and development of aortic dilation in early adulthood. Defects in FLNA are the cause of otopalatodigital syndrome type 1 (OPD1) [MIM:[http://omim.org/entry/311300 311300]]. OPD1 is an X-linked dominant multiple congenital anomalies disease mainly characterized by a generalized skeletal dysplasia, mild mental retardation, hearing loss, cleft palate, and typical facial anomalies. OPD1 belongs to a group of X-linked skeletal dysplasias known as oto-palato-digital syndrome spectrum disorders that also include OPD2, Melnick-Needles syndrome (MNS), and frontometaphyseal dysplasia (FMD). Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. FLNA is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers. Males with OPD1 have cleft palate, malformations of the ossicles causing deafness and milder bone and limb defects than those associated with OPD2. Obligate female carriers of mutations causing both OPD1 and OPD2 have variable (often milder) expression of a similar phenotypic spectrum.<ref>PMID:12612583</ref><ref>PMID:15940695</ref> Defects in FLNA are the cause of otopalatodigital syndrome type 2 (OPD2) [MIM:[http://omim.org/entry/304120 304120]]; also known as cranioorodigital syndrome. OPD2 is a congenital bone disorder that is characterized by abnormally modeled, bowed bones, small or absent first digits and, more variably, cleft palate, posterior fossa brain anomalies, omphalocele and cardiac defects. Defects in FLNA are the cause of frontometaphyseal dysplasia (FMD) [MIM:[http://omim.org/entry/305620 305620]]. FMD is a congenital bone disease characterized by supraorbital hyperostosis, deafness and digital anomalies.<ref>PMID:12612583</ref><ref>PMID:16596676</ref> Defects in FLNA are the cause of Melnick-Needles syndrome (MNS) [MIM:[http://omim.org/entry/309350 309350]]. MNS is a severe congenital bone disorder characterized by typical facies (exophthalmos, full cheeks, micrognathia and malalignment of teeth), flaring of the metaphyses of long bones, s-like curvature of bones of legs, irregular constrictions in the ribs, and sclerosis of base of skull.<ref>PMID:12612583</ref> Defects in FLNA are the cause of X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX) [MIM:[http://omim.org/entry/300048 300048]]. CIIPX is characterized by a severe abnormality of gastrointestinal motility due to primary qualitative defects of enteric ganglia and nerve fibers. Affected individuals manifest recurrent signs of intestinal obstruction in the absence of any mechanical lesion.<ref>PMID:17357080</ref> Defects in FLNA are the cause of FG syndrome type 2 (FGS2) [MIM:[http://omim.org/entry/300321 300321]]. FG syndrome (FGS) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation.<ref>PMID:17632775</ref> Defects in FLNA are the cause of terminal osseous dysplasia (TOD) [MIM:[http://omim.org/entry/300244 300244]]. A rare X-linked dominant male-lethal disease characterized by skeletal dysplasia of the limbs, pigmentary defects of the skin and recurrent digital fibroma during infancy. A significant phenotypic variability is observed in affected females.<ref>PMID:20598277</ref> Defects in FLNA are the cause of cardiac valvular dysplasia X-linked (CVDX) [MIM:[http://omim.org/entry/314400 314400]]. A rare X-linked heart disease characterized by mitral and/or aortic valve regurgitation. The histologic features include fragmentation of collagenous bundles within the valve fibrosa and accumulation of proteoglycans, which produces excessive valve tissue leading to billowing of the valve leaflets.<ref>PMID:17190868</ref> Note=Defects in FLNA may be a cause of macrothrombocytopenia, a disorder characterized by subnormal levels of blood platelets. Blood platelets are abonormally enlarged.
		+
		+	==Function==
		+	[[http://www.uniprot.org/uniprot/FLNA_HUMAN FLNA_HUMAN]] Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis.<ref>PMID:22121117</ref>

	==About this Structure==		==About this Structure==
Line 14:		Line 16:

	==Reference==		==Reference==
-	<ref group="xtra">PMID:019773341</ref><references group="xtra"/>	+	<ref group="xtra">PMID:019773341</ref><references group="xtra"/><references/>
	[[Category: Homo sapiens]]		[[Category: Homo sapiens]]
	[[Category: Clark, A R.]]		[[Category: Clark, A R.]]

OCA at 07:57, 20 October 2012

OCA — Sat, 20 Oct 2012 07:57:10 GMT

←Older revision		Revision as of 07:57, 20 October 2012
Line 8:		Line 8:

	==About this Structure==		==About this Structure==
-	[[3hop]] is a 2 chain structure ~~of [[Filamin]]~~ with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA].	+	[[3hop]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA].

	==See Also==		==See Also==

OCA at 17:59, 25 July 2012

OCA — Wed, 25 Jul 2012 17:59:12 GMT

←Older revision		Revision as of 17:59, 25 July 2012
Line 1:		Line 1:
	[[Image:3hop.png\|left\|200px]]		[[Image:3hop.png\|left\|200px]]

-	<!--
-	The line below this paragraph, containing "STRUCTURE_3hop", creates the "Structure Box" on the page.
-	You may change the PDB parameter (which sets the PDB file loaded into the applet)
-	or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-	or leave the SCENE parameter empty for the default display.
-	-->
	{{STRUCTURE_3hop\| PDB=3hop \| SCENE= }}		{{STRUCTURE_3hop\| PDB=3hop \| SCENE= }}

	===Structure of the actin-binding domain of human filamin A===		===Structure of the actin-binding domain of human filamin A===

-
-	<!--
-	The line below this paragraph, {{ABSTRACT_PUBMED_19773341}}, adds the Publication Abstract to the page
-	(as it appears on PubMed at http://www.pubmed.gov), where 19773341 is the PubMed ID number.
-	-->
	{{ABSTRACT_PUBMED_19773341}}		{{ABSTRACT_PUBMED_19773341}}

Line 22:		Line 11:

	==See Also==		==See Also==
-	*[[Filamin]]	+	*[[Filamin\|Filamin]]

	==Reference==		==Reference==
-	<ref group="xtra">PMID:~~19773341~~</ref><references group="xtra"/>	+	<ref group="xtra">PMID:019773341</ref><references group="xtra"/>
	[[Category: Homo sapiens]]		[[Category: Homo sapiens]]
	[[Category: Clark, A R.]]		[[Category: Clark, A R.]]
Line 31:		Line 20:
	[[Category: Sawyer, G M.]]		[[Category: Sawyer, G M.]]
	[[Category: Sutherland-Smith, A J.]]		[[Category: Sutherland-Smith, A J.]]
-	[[Category: Acetylation]]
	[[Category: Actin binding domain]]		[[Category: Actin binding domain]]
	[[Category: Actin-binding]]		[[Category: Actin-binding]]
-	[[Category: Alternative splicing]]
	[[Category: Calponin homology domain]]		[[Category: Calponin homology domain]]
-	[[Category: Cytoplasm]]
	[[Category: Cytoskeleton]]		[[Category: Cytoskeleton]]
	[[Category: Disease mutation]]		[[Category: Disease mutation]]
	[[Category: Phosphoprotein]]		[[Category: Phosphoprotein]]
-	[[Category: Polymorphism]]
	[[Category: Structural protein]]		[[Category: Structural protein]]

OCA: Protected "3hop" [edit=sysop:move=sysop]

OCA — Sun, 26 Dec 2010 20:43:22 GMT

Protected "3hop" [edit=sysop:move=sysop]

←Older revision

Revision as of 20:43, 26 December 2010

OCA at 20:43, 26 December 2010

OCA — Sun, 26 Dec 2010 20:43:20 GMT

←Older revision		Revision as of 20:43, 26 December 2010
Line 1:		Line 1:
-	{{Seed}}
	[[Image:3hop.png\|left\|200px]]		[[Image:3hop.png\|left\|200px]]

Line 18:		Line 17:
	-->		-->
	{{ABSTRACT_PUBMED_19773341}}		{{ABSTRACT_PUBMED_19773341}}
-
-	==Disease==
-	Known disease associated with this structure: Frontometaphyseal dysplasia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300017 300017]], Heterotopia, periventricular nodular, with frontometaphyseal dysplasia OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300017 300017]], Heterotopia, periventricular OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300017 300017]], Heterotopia, periventricular, ED variant OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300017 300017]], Melnick-Needles syndrome OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300017 300017]], Otopalatodigital syndrome, type I OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300017 300017]], Otopalatodigital syndrome, type II OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=300017 300017]]

	==About this Structure==		==About this Structure==
-	~~3HOP~~ is a 2 ~~chains~~ structure of ~~sequences~~ from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA].	+	[[3hop]] is a 2 chain structure of [[Filamin]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3HOP OCA].
		+
		+	==See Also==
		+	*[[Filamin]]

	==Reference==		==Reference==
Line 43:		Line 42:
	[[Category: Polymorphism]]		[[Category: Polymorphism]]
	[[Category: Structural protein]]		[[Category: Structural protein]]
-
-	''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 2 09:07:53 2009''